PTX 2.56% 4.0¢ prescient therapeutics limited

Ann: CSO Precision Medicine Presentation, page-35

  1. 5,787 Posts.
    lightbulb Created with Sketch. 1709
    Hi syzygy. Im picking you've read recent announcements but just in case. On 10 April 2018 the Co/ announced the PTX 200 Phase 1b Breast Cancer results and refered to commencement of Phase 2 results. They dont give insite into how long the trial will take through. Historically there has been quite a big lead in in the cohort "selection" process. Phase 2 seems to envisage a two stage testing programme 11 then a further 15. The prerequisites of stage two gave already been met with the first 5 of 11 cohorts. So all pretty promising. Heres a relevant exerpt from the above refered announcement. just in case you haven't seen it.

    a5c86325-50a9-403c-9356-38d4b95b8e82.png
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.0¢
Change
0.001(2.56%)
Mkt cap ! $32.21M
Open High Low Value Volume
4.0¢ 4.1¢ 3.9¢ $18.21K 455.2K

Buyers (Bids)

No. Vol. Price($)
2 95694 4.0¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 622328 4
View Market Depth
Last trade - 16.10pm 20/06/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.